COCHLEAR LIMITED — Regulatory Filings 2017

May 3, 2017

==> picture [595 x 141] intentionally omitted <==

ASX ANNOUNCEMENT

4 MAY 2017

COCHLEAR INVESTOR DAY PRESENTATIONS - CORRECTIONS

Cochlear Limited disclosed to the ASX a copy of the management presentations ( Presentations ) from an investor day hosted today at its global headquarters in Macquarie University.

Cochlear Limited wishes to make the following corrections in relation to the Presentations:

1. Presentation by Stu Sayers, President, Services

The second bullet point of the second slide should read:

Today it is over 25% on a base of ~330k Cochlear implant recipients, growing at 30-40k new Cochlear implant recipients pa

2. Presentation by Jan Janssen, SVP Design & Development

References for slides 5 and 11 of this presentation are as follows:

1. Holden, L.K., Finley, C.C., Firszt, J.B., Holden, T.A., Brenner, C., Potts, L.G., Gotter, B.D., Vanderhoof, S.S., Mispagel. K., Heydebrand, G. and Skinner, M.W. (2013). Factors affecting open-set word recognition in adults with cochlear implants. Ear Hear, 34, 342-260.

2. Skarzynski, H., Lorens, A., Matusiak, M., Porowski, M., Skarzynski, P.H., James, C.J. (2014). Cochlear implantation with the Nucleus Slim Straight Electrode in subjects with residual lowfrequency hearing. Ear Hear, Mar-Apr, 35(2), 33-43.

• **** ABI** means Auditory Brainstem Implant.

For further information, please contact:

Analysts

Kristina Devon Head of Investor Relations Email: kdevon@cochlear.com Ph: +61 2 9611 6691

Media

Piers Shervington Senior Manager Corporate Affairs Email: pshervington@cochlear.com Ph: +61 2 9425 5416

==> picture [595 x 67] intentionally omitted <==